Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Accumulated Expenses (2018 - 2025)

Historic Accumulated Expenses for Immucell (ICCC) over the last 14 years, with Q3 2025 value amounting to $977466.0.

  • Immucell's Accumulated Expenses fell 1443.14% to $977466.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $977466.0, marking a year-over-year decrease of 1443.14%. This contributed to the annual value of $1.2 million for FY2024, which is 2679.79% up from last year.
  • As of Q3 2025, Immucell's Accumulated Expenses stood at $977466.0, which was down 1443.14% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Immucell's Accumulated Expenses registered a high of $1.5 million during Q1 2022, and its lowest value of $291111.0 during Q1 2021.
  • Moreover, its 5-year median value for Accumulated Expenses was $942999.0 (2023), whereas its average is $902063.4.
  • In the last 5 years, Immucell's Accumulated Expenses soared by 42081.44% in 2022 and then plummeted by 5053.8% in 2023.
  • Immucell's Accumulated Expenses (Quarter) stood at $585939.0 in 2021, then soared by 64.96% to $966553.0 in 2022, then fell by 2.44% to $942999.0 in 2023, then rose by 26.8% to $1.2 million in 2024, then decreased by 18.25% to $977466.0 in 2025.
  • Its last three reported values are $977466.0 in Q3 2025, $1.1 million for Q2 2025, and $782390.0 during Q1 2025.